Geode Capital Management
COYA icon

Geode Capital Management’s Coya Therapeutics COYA Stock Holding History

Geode Capital Management’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$920K Buy
233,402
+35,414
+18% +$166K ﹤0.01% 3385
2025
Q4 		$1.15M Buy
197,988
+41,143
+26% +$250K ﹤0.01% 3330
2025
Q3 		$894K Sell
156,845
-242
-0.2% -$1.47K ﹤0.01% 3417
2025
Q2 		$903K Buy
157,087
+1,258
+0.8% +$7.29K ﹤0.01% 3357
2025
Q1 		$1.01M Buy
155,829
+5,253
+3% +$33.3K ﹤0.01% 3303
2024
Q4 		$863K Buy
150,576
+8,267
+6% +$56.3K ﹤0.01% 3422
2024
Q3 		$918K Buy
142,309
+4,485
+3% +$28.3K ﹤0.01% 3384
2024
Q2 		$835K Buy
137,824
+11,828
+9% +$95K ﹤0.01% 3379
2024
Q1 		$1.25M Buy
125,996
+33,531
+36% +$263K ﹤0.01% 3280
2023
Q4 		$685K Buy
92,465
+5,400
+6% +$30K ﹤0.01% 3495
2023
Q3 		$337K Buy
87,065
+28,492
+49% +$113K ﹤0.01% 3767
2023
Q2 		$238K Buy
+58,573
New +$272K ﹤0.01% 3965

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management's COYA Position: Q1 2026 in Review

Geode Capital Management increased its Coya Therapeutics (COYA) stake by 18% in Q1 2026, buying an estimated $166K and bringing the position to 233,402 shares worth $920K. The position accounts for ﹤0.01% of the portfolio, ranked #3385.

Geode Capital Management first reported a position in COYA in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.25M in Q1 2024. 56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

  • Geode Capital Management held 233,402 shares of Coya Therapeutics worth $920K as of Q1 2026.
  • Geode Capital Management bought 35,414 Coya Therapeutics shares in Q1 2026, an estimated $166K.
  • Coya Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3385 holding.
  • Geode Capital Management first reported a position in Coya Therapeutics in Q2 2023 and has held it in 12 quarters since.
  • Geode Capital Management's Coya Therapeutics position peaked at $1.25M in Q1 2024.
  • 56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.